LGC Biosearch Technologies

Petaluma, CA · Middleton, WI
Find alternatives to LGC Biosearch Technologies for Oligonucleotide →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: LGC Biosearch Technologies

Signal Score
63.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Petaluma, CA · Middleton, WI
Modalities
Oligonucleotide
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About LGC Biosearch Technologies

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesOligonucleotide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: LGC Group
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: LGC Group
Financial assessment: 68.0/100
Capacity 58.0
2 manufacturing sites
Sites: Petaluma, CA, Middleton, WI
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
2 manufacturing sites

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: smartrecruiters · Checked Nov 20, 2026

Frequently Asked Questions About LGC Biosearch Technologies

What is LGC Biosearch Technologies's CDMO Signal Score?
LGC Biosearch Technologies has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating LGC Biosearch Technologies for a manufacturing program?
Use the free AI matchmaker to compare LGC Biosearch Technologies against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs →

Similar CDMOs

Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
Signal Score: 77.4
Oligonucleotide
Agilent Technologies (Oligo GMP)
Boulder, CO · Frederick, CO
Signal Score: 74.2
Oligonucleotide

Compare LGC Biosearch Technologies with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on LGC Biosearch Technologies
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.